You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

East Asian Patients

Showing 1 - 25 of 2,798
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors, Advance Care Planning Trial (Culturally Tailored Digital Resilience-Building)

Not yet recruiting
  • Neoplasms
  • Advance Care Planning
  • Culturally Tailored Digital Resilience-Building
  • (no location specified)
Sep 6, 2023

Elidel® in South and East Asian Pediatric Atopic Dermatitis.

Not yet recruiting
  • Mild to Moderate Atopic Dermatitis
  • Elidel 1% Topical Cream
  • (no location specified)
Sep 18, 2023

Healthy Trial in London (UPB-101)

Active, not recruiting
  • Healthy
  • London, United Kingdom
    Richmond Pharmacology
Jan 19, 2023

The South-East Asian Transgender Health Cohort

Recruiting
  • HIV
  • +2 more
    • Pasay, Manila, Philippines
    • +3 more
    Jul 11, 2022

    Severe Aplastic Anemia (SAA) Trial in Worldwide (eltrombopag, rabbit anti-thymocyte globulin (r-ATG), cyclosporine A (CsA))

    Active, not recruiting
    • Severe Aplastic Anemia (SAA)
    • Zhengzhou, Henan, China
    • +11 more
    Jan 23, 2023

    Leukemia, Myeloid, Acute, MDS Trial in Japan, Korea, Republic of, Taiwan (Pevonedistat 25 mg/m^2, Pevonedistat 44 mg/m^2,

    Completed
    • Leukemia, Myeloid, Acute
    • Myelodysplastic Syndromes
    • Pevonedistat 25 mg/m^2
    • +4 more
    • Maebashi City, Japan
    • +8 more
    Jun 23, 2022

    Overweight and Obesity Trial in Japan, Korea, Republic of (semaglutide 50 mg, (semaglutide))

    Active, not recruiting
    • Overweight and Obesity
    • semaglutide 50 mg
    • placebo (semaglutide)
    • Ibaraki, Japan
    • +12 more
    Nov 10, 2022

    Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Marginal Zone Trial in Nagoya-shi, Chuo-ku, Seoul (TAK-659)

    Terminated
    Has Results
    • Lymphoma, Non-Hodgkin
    • Lymphoma, Follicular, Marginal Zone
    • Nagoya-shi, Aichi, Japan
    • +3 more
    Aug 17, 2021

    East Asian Breast Cancer Genome Atlas and Recurrence Risk

    Recruiting
    • Breast Cancer
    • PAM50
    • Taipei, Taiwan
      National Taiwan University Hospital
    May 6, 2021

    The Southeast and East Asian Post-Operative Delirium Study

    Recruiting
    • Postoperative Delirium
    • Hip Fractures
    • Neurocognitive tests
    • Sendai, Japan
    • +12 more
    Oct 11, 2021

    Acral Lentiginous Melanoma Trial in Hong Kong (pembrolizumab)

    Active, not recruiting
    • Acral Lentiginous Melanoma
    • Hong Kong, Hong Kong
      Department of Clinical Oncology, Prince of Wales Hospital
    Feb 15, 2022

    Advanced Nonhematological Tumors Trial in Japan, Korea, Republic of, Taiwan (TAK-228)

    Terminated
    Has Results
    • Advanced Nonhematological Neoplasms
    • Kashiwa-shi, Chiba-Ken, Japan
    • +3 more
    Apr 22, 2021

    Acute Myocardial Infarction Trial in Busan (Ticagrelor 90mg, Ticagrelor 60/45mg)

    Recruiting
    • Acute Myocardial Infarction
    • Ticagrelor 90mg
    • Ticagrelor 60/45mg
    • Busan, Korea, Republic of
      DongA University Hospital
    Feb 11, 2021

    Healthy Infants Trial in Manila (Control 1st age starter infant formula, Experimental1st age starter infant formula)

    Recruiting
    • Healthy Infants
    • Control 1st age starter infant formula
    • Experimental1st age starter infant formula
    • Manila, Philippines
    • +2 more
    Oct 2, 2023

    Advanced Solid Tumor Cancers, Medulloblastoma, Basal Cell Carcinoma Trial in Hong Kong, Japan, Taiwan (LDE225)

    Completed
    • Advanced Solid Tumor Cancers
    • +2 more
    • Hong Kong, Hong Kong
    • +3 more
    Dec 16, 2020

    Obesity or Overweight Trial in Japan, Taiwan (Cagrilintide, Semaglutide, Placebo Semaglutide)

    Not yet recruiting
    • Obesity or Overweight
    • Koriyama-shi, Fukushima, Japan, Japan
    • +21 more
    Apr 3, 2023

    Body Mass Index on Inpatient Stroke Rehabilitation Outcome: A

    Completed
    • Weight Change, Body
    • Stroke
    • No intervention
    • Singapore, Singapore
      Tan Tock Seng Hospital
    Nov 10, 2020

    COVID-19, SARS-CoV-2, Furin Trial in India, Ukraine, United States

    Recruiting
    • COVID-19
    • +4 more
      • Jacksonville, Florida
      • +8 more
      Aug 11, 2022

      Severity and Associated Factors in East Asian Moderate-to-severe

      Completed
      • Menopause
      • No intervention
      • Beijing, China
      • +2 more
      Nov 4, 2020

      Describing Chinese Herbal Medicine Telehealth Care for Symptoms

      Recruiting
      • Coronavirus Infection
      • Chinese Herbal Medicine
      • Seattle, Washington
        Seattle Intstitute of East Asian Medicine
      Sep 27, 2021

      Tumors Trial in Japan, Korea, Republic of, Taiwan (BI 754091, BI 754111)

      Active, not recruiting
      • Neoplasms
      • BI 754091
      • BI 754111
      • Chiba, Kashiwa, Japan
      • +12 more
      Aug 9, 2022

      Breast Tumors Trial in Worldwide (Palbociclib, Placebo, Tamoxifen)

      Active, not recruiting
      • Breast Neoplasms
      • Nagoya, Aichi, Japan
      • +22 more
      Apr 4, 2022

      Non Small Cell Lung Cancer, ROS1 Proto Oncogene, Crizotinib Trial in Worldwide (Crizotinib)

      Completed
      Has Results
      • Non Small Cell Lung Cancer
      • +2 more
      • Hefei, Anhui, China
      • +43 more
      Feb 3, 2021

      Overweight, Obesity Trial in Japan, Korea, Republic of (Semaglutide, Placebo (semaglutide))

      Completed
      Has Results
      • Overweight
      • Obesity
      • Adachi-ku, Tokyo, Japan
      • +27 more
      Feb 23, 2022

      Cardiometabolic Syndrome Trial in Malang (ß-1,3/1,6-D-Glucan From Mycelia Extract of Indonesia's Ganoderma Lucidum Group,

      Enrolling by invitation
      • Cardiometabolic Syndrome
      • β-1,3/1,6-D-Glucan From Mycelia Extract of Indonesia's Ganoderma Lucidum Group
      • Placebo Group
      • Malang, East Java, Indonesia
        General Hospital of Brawijaya University (Rumah Sakit Universita
      Oct 3, 2021